Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

GÜÇLÜ, ERTUĞRUL; Tuna, Nazan; Karabay, Oguz; Akhan, Sila; Bodur, Hurrem; Ceylan, Bahadir; Demirdal, Tuna; Demirdag, Kutbettin; DEMİRTÜRK, NEŞE; Ekerbicer, Hasan; Erol, Serpil; Esen, Saban; EVİRGEN, ÖMER; Geyik, Mehmet; Gunduz, Alper; Karahocagil, Mustafa; KÖKOĞLU, ÖMER; ÖZDEMİR, DAVUT; Ozgunes, Nail; Sargin, Fatma; Tosun, Selma; Tutuncu, Ediz

doi:10.3855/jidc.4953

Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B

GÜÇLÜ E., Tuna N., Karabay O., Akhan S., Bodur H., Ceylan B., ...Daha Fazla

JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, cilt.8, sa.12, ss.1601-1608, 2014 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 8 Sayı: 12
Basım Tarihi: 2014
Doi Numarası: 10.3855/jidc.4953
Dergi Adı: JOURNAL OF INFECTION IN DEVELOPING COUNTRIES
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1601-1608
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Introduction: Although pegylated interferons (pegIFNs) alpha-2a and alpha-2b have been used in chronic hepatitis B (CHB) treatment for many years, there are few studies concerning predictors of sustained virologic response (SVR) to pegIFN therapy. In this study, we aimed to investigate the predictors of response to pegIFN treatment in cases with HBeAg-negative CHB infection.